Temozolomide and capecitabine (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.

Date
2021
Author
Tastekin, Didem
Sakar, Burak
Karabulut, Senem
Dogan, Izzet
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/169634
https://doi.org/10.1200/jco.2021.39.3_suppl.366
Collections